Sort   by:  
 Page size 
UnknownSWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
Not available
S-EPMC4534524 | biostudies-literature
UnknownPharmacokinetics and safety of niraparib in patients with moderate hepatic impairment.
Not available
S-EPMC8484145 | biostudies-literature
UnknownUncovering a novel role of focal adhesion and interferon-gamma in cellular rejection of kidney allografts at single cell resolution.
Not available
S-EPMC10102512 | biostudies-literature
UnknownThe Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer.
Not available
S-EPMC3360546 | biostudies-literature
UnknownSARS-CoV-2 historical global testing and genomic variability.
Not available
S-EPMC8972777 | biostudies-literature
UnknownAKT Inhibition in Solid Tumors With AKT1 Mutations.
Not available
S-EPMC5501365 | biostudies-literature
UnknownPharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Not available
S-EPMC3174848 | biostudies-literature
UnknownMolecular pathogenesis and systemic therapies for hepatocellular carcinoma.
Not available
S-EPMC9060366 | biostudies-literature
UnknownPhase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
Not available
S-EPMC6075847 | biostudies-literature
UnknownA multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours.
Not available
S-EPMC7523345 | biostudies-literature
Sort   by:  
 Page size